Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Spectinomycin; Lincomycin
Laboratorios Maymó, S.A.
QJ01FF52
Spectinomycin; Lincomycin
444.7,222.0 milligram(s)/gram
Powder for use in drinking water
POM: Prescription Only Medicine as defined in relevant national legislation
lincomycin, combinations
Authorised
2020-03-06
Health Products Regulatory Authority 29 May 2020 CRN009L82 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Lismay 444.7 mg/g + 222.0 mg/g powder for use in drinking water for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: ACTIVE SUBSTANCES Spectinomycin (as spectinomycin sulfate tetrahydrate) . . . . . . . . . . . . . . . . . . . . . . . . . . . 444.7 mg Lincomycin (as lincomycin hydrochloride) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222.0 mg EXCIPIENTS Sodium Benzoate (E-211) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.67 mg For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Powder for use in drinking water. Whitish powder. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and metaphylaxis of porcine proliferative enteropathy (ileitis) caused by _Lawsonia intracellularis _and associated enteric pathogens (_Escherichia coli_) susceptible to lincomycin and spectinomycin. The presence of the disease in the group must be established before the product is used. 4.3 CONTRAINDICATIONS Do not use in known cases of hypersensitivity to the active substances or any of the excipients. Do not use in known cases of hepatic dysfunction. Do not allow rabbits or rodents (eg chinchillas, hamsters, guinea pigs), horses or ruminants to access to water or feed containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In _E. coli_, a significant part of the strains show high MIC values (minimum inhibitory concentrations) against the lincomycin and spectinomycin combination and may be clinically resistant, although no breakpoint is defined. Due to technical constraints, the susceptibility of _L. intracellularis _is difficult to test _in Citiți documentul complet